321 related articles for article (PubMed ID: 25809756)
1. Repurposing-a ray of hope in tackling extensively drug resistance in tuberculosis.
Maitra A; Bates S; Kolvekar T; Devarajan PV; Guzman JD; Bhakta S
Int J Infect Dis; 2015 Mar; 32():50-5. PubMed ID: 25809756
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.
Palomino JC; Martin A
Future Microbiol; 2016; 11(4):539-47. PubMed ID: 27070731
[TBL] [Abstract][Full Text] [Related]
4. Polypharmacological repurposing approach identifies approved drugs as potential inhibitors of Mycobacterium tuberculosis.
Singh J; Quadir N; Vashishtha S; Chakraborty A; Alam A; Kundu B; Ahmad U; Sundar D; Ehtesham NZ; Hasnain SE
Biochem J; 2023 Jul; 480(14):1079-1096. PubMed ID: 37306466
[TBL] [Abstract][Full Text] [Related]
5. Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
Palomino JC; Martin A
J Antimicrob Chemother; 2013 Feb; 68(2):275-83. PubMed ID: 23075693
[TBL] [Abstract][Full Text] [Related]
6. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
[TBL] [Abstract][Full Text] [Related]
7. Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Brouqui P; Quenard F; Drancourt M
Int J Antimicrob Agents; 2017 May; 49(5):554-557. PubMed ID: 28336312
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Immunomodulatory Drugs to Combat Tuberculosis.
Fatima S; Bhaskar A; Dwivedi VP
Front Immunol; 2021; 12():645485. PubMed ID: 33927718
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.
Nguyen HB; Nguyen NV; Tran HT; Nguyen HV; Bui QT
Western Pac Surveill Response J; 2016; 7(2):35-40. PubMed ID: 27508089
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis resistance in pulmonary TB patients in Cameroon: a phenotypic susceptibility assay.
Jubulis J; Dionne K; Osterhout G; Ayuk L; Awasom C; Achu P; Noeske J; Warren R; McArthur C; Parrish N
Int J Tuberc Lung Dis; 2015 Jul; 19(7):823-7. PubMed ID: 26056109
[TBL] [Abstract][Full Text] [Related]
11. Extensively Drug-Resistant Tuberculosis: Principles of Resistance, Diagnosis, and Management.
Wilson JW; Tsukayama DT
Mayo Clin Proc; 2016 Apr; 91(4):482-95. PubMed ID: 26906649
[TBL] [Abstract][Full Text] [Related]
12. Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis.
Vesenbeckh S; Krieger D; Bettermann G; Schönfeld N; Bauer TT; Rüssmann H; Mauch H
Tuberculosis (Edinb); 2016 May; 98():27-9. PubMed ID: 27156615
[TBL] [Abstract][Full Text] [Related]
13. Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1.
Lee H; Suh JW
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):205-12. PubMed ID: 26586403
[TBL] [Abstract][Full Text] [Related]
14. Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
Günther G; van Leth F; Altet N; Dedicoat M; Duarte R; Gualano G; Kunst H; Muylle I; Spinu V; Tiberi S; Viiklepp P; Lange C;
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1524-7. PubMed ID: 26614196
[TBL] [Abstract][Full Text] [Related]
15. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
[TBL] [Abstract][Full Text] [Related]
16. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
17. [Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].
Baylan O
Mikrobiyol Bul; 2011 Jan; 45(1):181-95. PubMed ID: 21341173
[TBL] [Abstract][Full Text] [Related]
18. New treatment options for multidrug-resistant tuberculosis.
Field SK; Fisher D; Jarand JM; Cowie RL
Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
[TBL] [Abstract][Full Text] [Related]
19. Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
Yew WW; Koh WJ
Korean J Intern Med; 2016 Jan; 31(1):15-29. PubMed ID: 26767853
[TBL] [Abstract][Full Text] [Related]
20. Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.
Maitra A; Bates S; Shaik M; Evangelopoulos D; Abubakar I; McHugh TD; Lipman M; Bhakta S
Br Med Bull; 2016 Jun; 118(1):138-48. PubMed ID: 27151954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
